21部委重磅新政!支持民营医院跨区域扩张

2019-09-30 欧阳峰 看医界(ID:vistamed)

继今年6月国家十部门出台社会办医22条支持政策后,为贯彻落实全国卫生与健康大会和《“健康中国2030”规划纲要》部署,加快推动健康产业发展,9月29日,国家发展改革委、国家卫生健康委等21部门联合下发《促进健康产业高质量发展行动纲要(2019-2022年)》,一波社会办医利好再度来袭。

中国社会办医又迎来重大利好了!

继今年6月国家十部门出台社会办医22条支持政策后,为贯彻落实全国卫生与健康大会和《“健康中国2030”规划纲要》部署,加快推动健康产业发展,9月29日,国家发展改革委、国家卫生健康委等21部门联合下发《促进健康产业高质量发展行动纲要(2019-2022年)》,一波社会办医利好再度来袭。

支持高水平民营医院跨区域办医!

文件明确表示支持优质社会办医扩容:“支持符合条件的高水平民营医院跨区域办医,向基层延伸,实现品牌化、集团化发展。”

这句话该怎么解读呢?众所周知,我国医疗水平及优质医疗资源存在较为严重的区域差距,那么该如何弥补这一巨大的差距呢?除了依托当地优质医疗资源建设区域医疗中心外,如何进一步动用市场的活力促进优质医疗资源的跨区域下沉呢?

此次,文件给出了明确的信号:支持符合条件的高水平民营医院跨区域办医。

也就是说,一批诸如三博脑科、武汉亚心、爱尔眼科等民营医疗龙头或将成为国家支持跨区域发展的对象。

既然是支持,那就不太可能仅仅是口头上的,从负责执行的几大部门:卫生健康委、发展改革委、中医药局负责来看,未来或将主要在高水平民营医院跨区域办医的市场准入等方面迎来支持。

由于文件明确指出支持发展的方向是向基层延伸,因此未来或将鼓励这些医院在跨区域的地市级城市办医,为基层带来市场化的优质、高水平医疗服务。

值得关注的是,文件仅仅提出支持符合条件的高水平民营医院跨区域办医,并没有提出支持符合条件的高水平公立医院跨区域办医,这意味着什么?

对此业内人士表示,在跨区域办医方面,国家未来将重点鼓励市场化的社会办医,而不是公立医院的跨区域开分院。

据了解,近年来有不少大型公立医院实现了跨区域大型分院的建设,但诸如协和、华西在内的不少顶级医院并未涉足跨区域扩张,也就说,未来这一块蛋糕将主要留给民营医疗。

对此业内人士表示,一些高水平的专科民营医院将迎来较好的发展机遇,但标准化的优质医疗人才培养目前还是民营医疗跨区域发展的较大阻碍。

解放医生生产力:兼职开诊所时代来了!

此外,文件还表示,将开展诊所改革试点,简化诊所准入程序,完善诊所基本标准,试点诊所备案管理,鼓励医师全职或兼职举办诊所。

放开诊所准入这一点与不久前十部门支持社会办医22条政策是一致的,根据22条,2019—2020年,在北京、上海、沈阳、南京、杭州、武汉、广州、深圳、成都、西安等10个城市开展诊所备案管理试点。试点城市跨行政区域经营的连锁化、集团化诊所由上一级卫生健康行政部门统一备案,跨省级行政区划经营的,由所在省份卫生健康行政部门分别备案。

可以预期的是,未来几年试点或将扩展到全国主要城市。

另外,可与预见的是,随着“鼓励医师全职或兼职举办诊所”政策的细化和落地,未来几年,我国或将迎来医生兼职办诊所潮,不少医生将身兼诊所老板,白天在医院看病,晚上在诊所坐诊的情况或将越来越多。

以改革的前沿深圳为例,就已经出现了三甲公立医院允许医生兼职开诊所的案例,而不是偷偷摸摸。

此外,文件还表示,将进一步发挥社会办医机制灵活、贴近群众的优势,支持社会力量举办全科医疗、专科医疗、中医药、第三方医技服务、康复、护理、安宁疗护等机构,与公立医院协同发展。

关于利好社会办医新政的持续出台,中国非公立医疗机构协会常务副会长兼秘书长郝德明表示,按照目前政策红利下的高速发展态势,社会办医会迎来持续爆发,社会办医疗机构2020年或将以每天20家左右的速度增长。

这么多医疗机构的开业,医生从哪里来?

这一点,或许促进健康产业高质量发展的十大重点工程的第六项“健康保险发展深化工程”中的一句话中一窥端倪:“加快适用于多机构执业的医生执业责任险产品准入,鼓励医生、医师协会等参与医生执业责任险产品开发。”

也就是说,解放医生、促进优质医生资源的流动将是鼓励的重点。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1684806, encodeId=bbb2168480603, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat Apr 04 13:58:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080040, encodeId=5a93208004017, content=<a href='/topic/show?id=b4ff930e362' target=_blank style='color:#2F92EE;'>#跨区域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93073, encryptionId=b4ff930e362, topicName=跨区域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Sun Mar 22 14:58:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752581, encodeId=23a51e5258100, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Sat Oct 26 01:58:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425583, encodeId=c1ff14255831c, content=<a href='/topic/show?id=b04463e47bb' target=_blank style='color:#2F92EE;'>#民营医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63747, encryptionId=b04463e47bb, topicName=民营医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5213977322, createdName=LSJ112, createdTime=Wed Oct 02 00:58:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549516, encodeId=07ab154951618, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Oct 02 00:58:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
    2020-04-04 lsj637
  2. [GetPortalCommentsPageByObjectIdResponse(id=1684806, encodeId=bbb2168480603, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat Apr 04 13:58:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080040, encodeId=5a93208004017, content=<a href='/topic/show?id=b4ff930e362' target=_blank style='color:#2F92EE;'>#跨区域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93073, encryptionId=b4ff930e362, topicName=跨区域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Sun Mar 22 14:58:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752581, encodeId=23a51e5258100, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Sat Oct 26 01:58:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425583, encodeId=c1ff14255831c, content=<a href='/topic/show?id=b04463e47bb' target=_blank style='color:#2F92EE;'>#民营医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63747, encryptionId=b04463e47bb, topicName=民营医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5213977322, createdName=LSJ112, createdTime=Wed Oct 02 00:58:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549516, encodeId=07ab154951618, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Oct 02 00:58:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1684806, encodeId=bbb2168480603, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat Apr 04 13:58:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080040, encodeId=5a93208004017, content=<a href='/topic/show?id=b4ff930e362' target=_blank style='color:#2F92EE;'>#跨区域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93073, encryptionId=b4ff930e362, topicName=跨区域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Sun Mar 22 14:58:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752581, encodeId=23a51e5258100, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Sat Oct 26 01:58:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425583, encodeId=c1ff14255831c, content=<a href='/topic/show?id=b04463e47bb' target=_blank style='color:#2F92EE;'>#民营医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63747, encryptionId=b04463e47bb, topicName=民营医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5213977322, createdName=LSJ112, createdTime=Wed Oct 02 00:58:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549516, encodeId=07ab154951618, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Oct 02 00:58:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1684806, encodeId=bbb2168480603, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat Apr 04 13:58:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080040, encodeId=5a93208004017, content=<a href='/topic/show?id=b4ff930e362' target=_blank style='color:#2F92EE;'>#跨区域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93073, encryptionId=b4ff930e362, topicName=跨区域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Sun Mar 22 14:58:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752581, encodeId=23a51e5258100, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Sat Oct 26 01:58:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425583, encodeId=c1ff14255831c, content=<a href='/topic/show?id=b04463e47bb' target=_blank style='color:#2F92EE;'>#民营医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63747, encryptionId=b04463e47bb, topicName=民营医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5213977322, createdName=LSJ112, createdTime=Wed Oct 02 00:58:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549516, encodeId=07ab154951618, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Oct 02 00:58:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1684806, encodeId=bbb2168480603, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat Apr 04 13:58:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080040, encodeId=5a93208004017, content=<a href='/topic/show?id=b4ff930e362' target=_blank style='color:#2F92EE;'>#跨区域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93073, encryptionId=b4ff930e362, topicName=跨区域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Sun Mar 22 14:58:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752581, encodeId=23a51e5258100, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Sat Oct 26 01:58:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425583, encodeId=c1ff14255831c, content=<a href='/topic/show?id=b04463e47bb' target=_blank style='color:#2F92EE;'>#民营医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63747, encryptionId=b04463e47bb, topicName=民营医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5213977322, createdName=LSJ112, createdTime=Wed Oct 02 00:58:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549516, encodeId=07ab154951618, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Oct 02 00:58:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
    2019-10-02 xxxx1054

相关资讯

公立医院不许参加境外评审,JCI评审和HIMSS评级将被叫停?

近日,在2019中国医院协会信息网络大会医院信息领导力论坛上,国家卫生健康委员会医政医管局副局长焦雅辉明确表示:“我跟所有公立医院院长都反复讲一个要求——至少在我负责这项工作期间,不允许任何公立医院参加由境外第三方组织的任何评价工作,如果再有公立医院参加评价并以此作为业绩加以宣传,一旦被我发现,我就要去查这家医院的安全问题”。

一位院长的体制外13年

近日,“你是我的眼——角膜移植西部行”公益项目走进西宁,在连续做了五台角膜移植手术后,北京爱尔英智眼科医院CEO李绍伟院长向“医学界”讲述了他在体制外的这10多年。

医保支付改革下的民营医院如何转型

在2018年国家医保局成立之后,从药品带量采购到DRG试点正式启动,从异地就医医保直接结算到医保基金监管强化,医保支付体系改革进程明显加快。虽然目前医保改革的重点主要集中在公立医院,但对民营医院的影响正在逐步显现。随着支付方加快支付模式的整体性改革,民营医院的传统发展模式很难再维持下去,必须进行系统性的转型。

浙江首份民营医院参与医共体文件落地

“对于推广政府购买服务,我有个建议,就是光购买不够,现在全国有一个医共体建设的一个高潮。所以我建议要把我们的社会办医纳入到区域的医共体、医联体建设的这个体系里面。”在上月由中国非公立医疗机构协会主办的《关于促进社会办医持续健康规范发展的意见》新闻发布会上,原浙江省卫生信息中心主任倪荣表示。今日,“医学界”获悉,浙江省卫生健康委、浙江省医疗保障局联合下发了《关于支持社会办医疗机构参与县域医疗卫生

49家医疗机构上“黑榜”2019上半年触红线机构一览

2019年8月底,上海卫健委监督所通报了 2019上半年医疗机构违法广告。有49家医疗机构因医疗广告违法受到行政处罚。

DRG付费来势汹汹 民营医院该如何突围?

5月20日,国家医保局召开疾病诊断相关分组(DRG)付费国家试点工作启动视频会议。会议宣布将在30个城市开展DRG付费试点工作,该工作按照“顶层设计、模拟运行、实际付费”分三年有序推进,通过试点实现“五个一”的目标,即制定一组标准、完善一系列政策、建立一套规程、培养一支队伍、打造一批样板。 DRG付费,是根据住院病人的病情严重程度、治疗方法的复杂程度、诊疗的资源消耗(成本)程度以及合并症、并